Results 111 to 117 of about 1,368 (117)

The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study

Lancet, The, 2016
Ziad Hijazi, Jonas Oldgren, Johan Lindbäck   +2 more
exaly  

Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis

Lancet, The, 2014
Dipak Kotecha, Fesc, Jane Holmes, Douglas G Altman   +2 more
exaly  

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

Lancet, The, 2014
Christian Ruff, Robert P Giugliano, Eugene Braunwald   +2 more
exaly  

Atrial septal defects

Lancet, The, 2014
Tal Geva, Jose Martins
exaly  

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

Lancet, The, 2007
Jonathan Mant, Richard Hobbs, Gregory Lip   +2 more
exaly  

Atrial fibrillation: strategies to control, combat, and cure

Lancet, The, 2002
Nicholas S Peters, Prapa Kanagaratnam Frcp, Vias Markides   +2 more
exaly  

Prevalence of atrial fibrillation and eligibility for anticoagulants in the community

Lancet, The, 1998
Richard Thomson, Helen Rodgers, Rose Anne Kenny   +2 more
exaly